☐ | | | Preliminary Proxy Statement |
☐ | | | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | | | Definitive Proxy Statement |
☐ | | | Definitive Additional Materials |
☐ | | | Soliciting Material Pursuant to Sec.240.14a-12 |
FTI CONSULTING, INC. |
(Name of Registrant as Specified In Its Charter) |
Not Applicable |
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
☒ | | | No fee required. | |||
☐ | | | Fee paid previously with preliminary materials. | |||
☐ | | | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
![]() | | | Meeting Date: June 1, 2022 | | | ![]() | | | Meeting Place: 555 12th Street NW Suite 700 Washington, D.C. 20004 | | | ![]() | | | Meeting Time: 9:30 a.m. (EDT) | | | ![]() | | | Record Date: March 3, 2022 |
| | | | |||||||||
| | Proposal Number | | | Proposal | | | Board of Directors Voting Recommendation | | | ||
| | No. 1 | | | Consider and vote upon the election as directors of the ten nominees named in the proxy statement | | | FOR each nominee | | | ||
| | No. 2 | | | Consider and vote upon the ratification of the appointment of KPMG LLP as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2022 | | | FOR | | | ||
| | No. 3 | | | Consider and vote upon an advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2021 as described in the proxy statement | | | FOR | | | ||
| | | | The transaction of any other business that may properly come before the meeting or any postponement or adjournment thereof | | | N/A | | | |||
| | Postponements and Adjournments: | | | Any action on the items of business described above may be considered at the meeting, at the time and on the date specified above or at any time and date to which the meeting may be properly postponed or adjourned. | | | |||||
| | In-Person Meeting Admission: | | | Admission will be by ticket only. Please follow the advance registration instructions set forth in the section of the Proxy Statement titled “Information about the Annual Meeting and Voting — How Do I Attend the Annual Meeting?” beginning on page 5 of the Proxy Statement. If you do not provide an admission ticket and comply with the photo identification requirements outlined beginning on page 5, you will not be admitted to the 2022 annual meeting. Cameras, recording devices and other electronic devices will not be permitted at the 2022 annual meeting. | | | |||||
| | Annual Meeting Location: | | | The 2022 annual meeting of shareholders is currently scheduled to be held at 555 12th Street NW, Suite 700, Washington, D.C. 20004. However, as part of our precautions regarding the coronavirus disease 2019 (COVID-19), we are planning for the possibility that the annual meeting may be held solely by means of remote communication. If we take this step, we will announce the decision to do so in advance, and details on how to participate will be set forth in a press release issued by the Company and available at https://ir.fticonsulting.com/press-releases and https://www.virtualshareholdermeeting.com/FCN2022, where you will also find information on how to attend the virtual meeting. | | | |||||
| | Voting: | | | YOUR VOTE IS VERY IMPORTANT. Whether or not you plan to attend the meeting, we hope you will authorize a proxy to vote on your behalf as soon as possible. For specific instructions on how to authorize a proxy to vote your shares, please refer to the section titled “Information about the Annual Meeting and Voting” beginning on page 2 of the Proxy Statement. Make sure to have your proxy card or voting instruction form in hand to authorize a proxy to vote your shares. You may vote or authorize a proxy to vote your shares as follows: | | |
![]() | | | In person at the Annual Meeting held in person | | | ![]() | | | By telephone at +1.800.690.6903 | | | ![]() | | | Over the Internet at www.proxyvote.com | | | ![]() | | | By mailing your completed proxy card in the envelope provided |
By Order of the Board of Directors, ![]() Joanne F. Catanese Associate General Counsel and Corporate Secretary April 15, 2022 |
| Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to Be Held on June 1, 2022 (the “Annual Meeting”): We mailed a Notice of Internet Availability of Proxy Materials containing instructions on how to access our Proxy Statement for the Annual Meeting and our 2021 Annual Report on or about April 15, 2022. Our Proxy Statement and Annual Report are available online at www.proxyvote.com. | |
| Date: | | | June 1, 2022 | |
| Time: | | | 9:30 a.m., Eastern Daylight Time | |
| Location: * | | | FTI Consulting, Inc. 555 12th Street NW Suite 700 Washington, D.C. 20004 | |
| Record Date: | | | Close of business on March 3, 2022 | |
| Stock Symbol: | | | FCN | |
| Exchange: | | | New York Stock Exchange (the “NYSE”) | |
| Common Stock Outstanding as of the Close of Business on the Record Date Entitled to Vote at the Annual Meeting: | | | 34,432,204 shares of common stock, par value $0.01 per share (“Common Stock”) | |
| Registrar and Transfer Agent: | | | American Stock Transfer & Trust Company | |
| State of Incorporation: | | | Maryland | |
| Year of Incorporation: | | | 1982 | |
| Public Company Since: | | | 1996 | |
| Corporate Website: | | | www.fticonsulting.com | |
* | The 2022 annual meeting of shareholders is currently scheduled to be held at 555 12th Street NW, Suite 700, Washington, D.C. 20004. However, as part of our precautions regarding the coronavirus disease 2019 (“COVID-19”), we are planning for the possibility that the annual meeting may be held solely by means of remote communication. If we take this step, we will announce the decision to do so in advance, and details on how to participate will be set forth in a press release issued by the Company and available at https://ir.fticonsulting.com/press-releases and https://www.virtualshareholdermeeting.com/FCN2022, where you will also find information on how to attend the virtual meeting. |
(1) | See Appendix A for the definitions of EBITDA, as adjusted (“Adjusted EBITDA”), and other financial measures for financial reporting purposes referred to in this proxy statement (“Proxy Statement”) that have not been presented or prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and are considered not in conformity with GAAP (“non-GAAP”) under the rules promulgated by the SEC, and the reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures. Certain of these non-GAAP financial measures are not defined the same as the similarly-named financial measures used to establish annual incentive pay (“AIP”) for the year ended December 31, 2021 (“2021 AIP”). See the section of this Proxy Statement titled “Information about our Executive Officers and Compensation — Compensation Discussion and Analysis — 2021 Pay Outcomes — 2021 Annual Incentive Pay — Financial Metrics” beginning on page 51 and Appendix B for the definitions of similarly-named non-GAAP financial measures for determining 2021 AIP, and Appendix B for the reconciliations of such non-GAAP financial measures to the most directly comparable GAAP financial measures. |
(2) | “Equity Market Capitalization” for the years 2018 and 2021 has been calculated by multiplying (i) the number of total shares of Common Stock outstanding on December 31 of the applicable year by (ii) the closing price per share of Common Stock of the Company reported on the NYSE for December 31 of the applicable year. |
(1) | “Organic Revenue Growth” has been calculated excluding the impact of acquisitions and foreign currency (FX) translation in each of the years presented. |
(2) | See Appendix A for the definitions of Adjusted EBITDA, earnings per diluted share, as adjusted (“Adjusted EPS”), Free Cash Flow and other non-GAAP financial measures for financial reporting purposes referred to in this Proxy Statement and the reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures. Certain of these non-GAAP financial measures are not defined the same as the similarly-named financial measures used to establish annual incentive pay (“AIP”). See “Information about Our Executive Officers and Compensation — Compensation Discussion & Analysis — 2021 Pay Outcomes — 2021 Annual Incentive Pay — Financial Metrics” beginning on page 51 and Appendix B for the definitions of similarly-named financial measures for determining the AIP of our named executive officers for the year ended December 31, 2021, and Appendix B for the reconciliations of such non-GAAP financial measures to the most directly comparable GAAP financial measures. |
— | The FTI Hispanic/Latinx Organization for Leadership and Advancement (HOLA) initiative. |
— | A microaggressions training for all Consultant and Senior Consultant level professionals. |
— | FTI WIN Drive, a coaching program for Senior Director level and above female professionals, which focuses on supporting participants in achieving personal career goals, among other topics, and provides small group coaching on business development, business origination, cross-segment networking and more. |
— | Employees logged more than 88,500 training hours. |
— | Average annual training hours per employee of 13.1 hours. |
| | | | | | |||
| | | Annual Cash Base Salary | | | Fixed element of annual compensation No change to base salary levels for 2021 from 2020 | | |
| | | Annual Incentive Pay (“AIP”) Program | | | Short-term cash incentive with variable payout opportunities based on Adjusted EPS, Adjusted EBITDA and individual performance measured against annual performance goals No change to types of AIP payout opportunities for 2021 from 2020 | | |
| | | Long-Term Incentive Pay (“LTIP”) Program | | | Long-term equity incentives in the forms of time-based awards of shares of restricted stock (“RSAs”) and performance-based awards of restricted stock units (“Performance RSUs”) with multi-year vesting schedules No change to types of LTIP equity award opportunities for 2021 from 2020 | | |
| | | | | |
| 2021 CEO’s Compensation at Target | | | 2021 Other NEOs’ Compensation at Target | |
| ![]() | | | ![]() | |
![]() | | | Fall Informed by our summer report, we extend an invitation to our 20 largest shareholders to assess corporate governance and compensation trends and practices that are important to them. Winter Report shareholder feedback from our fall meetings to the Board and use shareholder feedback to enhance our proxy disclosure and make appropriate changes to our governance practices and executive compensation program. Spring Conduct follow-up conversations with our largest shareholders and extend an invitation to our 20 largest shareholders to discuss important issues that will be considered at our upcoming annual meeting. Summer Prepare a report for the Board that includes a review of voting results and feedback we received from our shareholders during the proxy season. This discussion informs outreach and engagement plans for our meetings with shareholders during the fall. |
90% Independent Directors | | | 30% Female Directors | | | 30% Racially Diverse Directors | | | 8.3 Years Average Tenure (Range - 0 to 18 years) | | | 65.9 Average Age | | | 20% Directors Based Outside of U.S. |
| | | | |||||||||||||||||||||
| | | | Committee Membership | | | ||||||||||||||||||
| | Director | | | Age | | | Director Since | | | Independent Directors | | | Audit | | | Compensation | | | Nominating, Corporate Governance and Social Responsibility | | | ||
| | Gerard E. Holthaus Lead Independent Director of WillScot Mobile Mini Holdings Corp. | | | 72 | | | 2004 | | | ![]() | | | • | | | • | | | | | |||
| | Steven H. Gunby President and Chief Executive Officer of FTI Consulting, Inc. | | | 64 | | | 2014 | | | | | | | | | | | ||||||
| | Brenda J. Bacon President and Chief Executive Officer of Brandywine Senior Living LLC | | | 71 | | | 2006 | | | ✔ | | | | | • | | | C | | | |||
| | Mark S. Bartlett Former Partner at Ernst & Young LLP | | | 71 | | | 2015 | | | ✔ | | | • | | | | | | | ||||
| | Claudio Costamagna Chairman of CC e Soci S.r.l. | | | 66 | | | 2012 | | | ✔ | | | | | C | | | | | ||||
| | Sir Vernon Ellis Former Chair of the Board of Trustees of the British Council | | | 74 | | | 2012 | | | ✔ | | | • | | | | | • | | | |||
| | Nicholas C. Fanandakis Senior Adviser to the Chief Executive Officer of DuPont de Nemours, Inc. | | | 65 | | | 2014 | | | ✔ | | | C | | | | | | | ||||
| | Nicole S. Jones (1) Executive Vice President and General Counsel of Cigna Corporation | | | 52 | | | 2022 | | | ✔ | | | | | | | | | |||||
| | Stephen C. Robinson (1) Retired Partner of the Law Firm of Skadden, Arps, Slate, Meagher & Flom LLP | | | 65 | | | 2022 | | | ✔ | | | | | | | | | |||||
| | Laureen E. Seeger Chief Legal Officer of the American Express Company | | | 60 | | | 2016 | | | ✔ | | | | | • | | | • | | |
(1) | On March 22, 2022, Nicole S. Jones and Stephen C. Robinson were elected by the Board to fill vacancies resulting from its increase of the size of the Board to ten directors from eight directors. Ms. Jones and Mr. Robinson have not been elected to Committee assignments. |
![]() | Independent Chairman of the Board |
C | Committee Chair |
| Proposal Number | | | Proposal | | | Board of Directors Voting Recommendation | |
| No. 1 | | | Consider and vote upon the election as directors of the ten nominees named in the Proxy Statement | | | FOR each nominee | |
| Each of the ten directors has been nominated by the Board to stand for election as a director of the Company. Each nominee, if elected, will serve as a director for a term until the next annual meeting of shareholders and until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or removal (whichever occurs earliest). (See page 12) | | ||||||
| No. 2 | | | Consider and vote upon the ratification of the appointment of KPMG LLP as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2022 | | | FOR | |
| Our Audit Committee has appointed KPMG LLP (“KPMG”) as the independent registered public accounting firm to audit our books and records for the year ending December 31, 2022. KPMG has acted as our auditor since 2006. We are offering shareholders the opportunity to ratify the appointment of our independent registered public accounting firm as a matter of good corporate governance practice. (See page 30) | | ||||||
| No. 3 | | | Consider and vote upon an advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2021 as described in the proxy statement | | | FOR | |
| In accordance with applicable law and the preference of our shareholders to cast an advisory (non-binding) vote on say-on-pay every year, we are affording our shareholders the opportunity to cast an advisory (non-binding) vote to approve the following resolution: | | ||||||
| “RESOLVED, that the shareholders approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers for the year ended December 31, 2021 as described in the Proxy Statement for the 2022 Annual Meeting of Shareholders.” | | ||||||
| | | The transaction of any other business that may properly come before the meeting or any postponement or adjournment thereof | | | N/A | |
| Proposal No. 1: Elect as directors the ten nominees named in the Proxy Statement | | | As there are ten nominees for the ten director seats up for election, each nominee will be elected as a director if he or she receives the affirmative vote of a majority of the total votes cast “FOR” and “WITHHELD” with respect to his or her election as a director at the Annual Meeting. Any abstentions or broker non-votes are not counted as votes cast either “FOR” or “WITHHELD” with respect to a director’s election and will have no effect on the election of directors. The Board recommends a vote FOR the election of each nominee as a director. | |
| Proposal No. 2: Ratify the appointment of KPMG LLP (“KPMG”) as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2022 | | | Ratification of the appointment of KPMG as the Company’s independent registered public accounting firm for the year ending December 31, 2022 requires a majority of the votes cast on the proposal at the Annual Meeting to be voted “FOR” this proposal. Abstentions will not count as votes cast either “FOR” or “AGAINST” Proposal No. 2 and will have no effect on the results of the vote on this proposal. Discretionary voting is permitted by the NYSE on this proposal, and, therefore, we do not anticipate any broker non-votes for this proposal. The Board recommends a vote FOR the ratification of the appointment of KPMG. | |
| Proposal No. 3: Vote on an advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2021 as described in the Proxy Statement | | | The approval of an advisory resolution approving the compensation of our named executive officers for the year ended December 31, 2021 as described in this Proxy Statement for the Annual Meeting requires a majority of the votes cast on this proposal at the Annual Meeting to be voted “FOR” this proposal. Abstentions and broker non-votes will not be counted as votes cast either “FOR” or “AGAINST” Proposal No. 3 and will have no effect on this proposal. However, this proposal is an advisory (non-binding) proposal. The Board recommends a vote FOR the advisory (non-binding) resolution to approve the compensation of our named executive officers for the year ended December 31, 2021 as described in the Proxy Statement. | |
| | | | |||||||||||||||||||||||||||||||||
| | Director | | | Leadership | | | Finance and Accounting | | | Services or Industry | | | Government | | | Other Public Company Board Experience | | | Global | | | Gender Diversity | | | Racial Diversity | | | Independence | | ||||||
| | ![]() | | | Brenda J. Bacon | | | • | | | • | | | • | | | • | | | • | | | | | • | | | • | | | • | | | |||
| | ![]() | | | Mark S. Bartlett | | | • | | | • | | | • | | | | | • | | | • | | | | | | | • | | | |||||
| | ![]() | | | Claudio Costamagna | | | • | | | • | | | • | | | | | • | | | • | | | | | | | • | | | |||||
| | ![]() | | | Vernon Ellis | | | • | | | • | | | • | | | • | | | | | • | | | | | | | • | | | |||||
| | ![]() | | | Nicholas C. Fanandakis | | | • | | | • | | | • | | | | | • | | | • | | | | | | | • | | | |||||
| | ![]() | | | Steven H. Gunby | | | • | | | • | | | • | | | | | • | | | • | | | | | | | | | ||||||
| | ![]() | | | Gerard E. Holthaus | | | • | | | • | | | • | | | | | • | | | • | | | | | | | • | | | |||||
| | ![]() | | | Nicole S. Jones | | | • | | | | | • | | | | | | | | | • | | | • | | | • | | |
| | | | |||||||||||||||||||||||||||||||||
| | Director | | | Leadership | | | Finance and Accounting | | | Services or Industry | | | Government | | | Other Public Company Board Experience | | | Global | | | Gender Diversity | | | Racial Diversity | | | Independence | | ||||||
| | ![]() | | | Stephen C. Robinson | | | • | | | | | • | | | • | | | • | | | | | | | • | | | • | | | |||||
| | ![]() | | | Laureen E. Seeger | | | • | | | | | • | | | | | • | | | • | | | • | | | | | • | | |
90% Independent Directors | | | 30% Female Directors | | | 30% Racially Diverse Directors | | | 8.3 Years Average Tenure (Range - 0 to 18 years) | | | 65.9 Average Age | | | 20% Directors Based Outside of U.S. |
| 2022 Director Nominees | | |||
| Brenda J. Bacon | | | Steven H. Gunby | |
| Mark S. Bartlett | | | Gerard E. Holthaus | |
| Claudio Costamagna | | | Nicole S. Jones | |
| Vernon Ellis | | | Stephen C. Robinson | |
| Nicholas C. Fanandakis | | | Laureen E. Seeger | |
| 2022 Nominees for Director | | | Principal Occupation and Business Experience | |
| ![]() Independent Director Director Since: 2006 Age: 71 | | | Brenda Bacon has been the President and Chief Executive Officer of Brandywine Senior Living LLC for more than 15 years. Ms. Bacon co-founded Brandywine Living in 1996. Brandywine Senior Living LLC currently has 32 operating properties in seven states, with additional communities in development. Brandywine Senior Living LLC is a growing platform for luxury senior living with supportive services. Ms. Bacon served as Chief of Management and Planning, a cabinet-level position for the State of New Jersey, under former New Jersey Governor James J. Florio from 1989 to 1993. During President William J. Clinton’s first term, Ms. Bacon was on loan to the Presidential Transition Team as co-chair for the transition of the Department of Health and Human Services. Public Company Directorships and Committees: Hilton Grand Vacations Inc. [Member of Audit Committee and Nominating and Corporate Governance Committee] Select Non-Public Directorships and Committees: Argentum [Director] Rowan University [Trustee] [Member of University Advancement Committee] | |
| ![]() Independent Director Director Since: 2015 Age: 71 | | | Mark Bartlett has extensive accounting and financial services experience, having retired as a Partner of Ernst & Young LLP (“Ernst & Young”), a leading accounting firm, in June 2012. Mr. Bartlett joined Ernst & Young in 1972 and worked there until his retirement, serving as Managing Partner of the firm’s Baltimore office and Senior Client Service Partner for the Mid-Atlantic region. He is a certified public accountant. Public Company Directorships and Committees: T. Rowe Price Group, Inc. [Chair of Audit Committee and Member of Executive Compensation and Management Development Committee] Willscot Mobile Mini Holdings Corp. [Chair of Audit Committee and Member of Compensation Committee] Zurn Water Solutions Corporation [Lead Independent Director] [Chair of Audit Committee and Member of Executive Committee] Select Non-Public Directorships and Committees: The Baltimore Life Companies [Chair of Audit Committee] | |
| 2022 Nominees for Director | | | Principal Occupation and Business Experience | |
| ![]() Independent Director Director Since: 2012 Age: 66 | | | Claudio Costamagna is Chairman of CC e Soci S.r.l., a financial advisory firm he founded in June 2007, and CC Holdings S.r.L., its parent company. Mr. Costamagna has extensive experience in investment banking, having served for 18 years, until April 2006, in various positions with The Goldman Sachs Group, Inc., culminating as Chairman of the Investment Banking Division in Europe, the Middle East and Africa from December 2004 to March 2006. Public Company Directorships and Committees: Advanced Accelerator Applications S.A. [Chairman] REVO — SPAC [Chairman] Select Non-Public Directorships and Committees: CC e Soci S.r.l. [Chairman] Ferragamo Finanziaria S.p.A. Finavedi S.p.A. Italiana Petroli S.p.A. Salini Costruttori S.p.A. | |
| ![]() Independent Director Director Since: 2012 Age: 74 | | | Sir Vernon Ellis served as Chair of the Board of Trustees of the British Council, the United Kingdom’s international organization for cultural relations and education opportunities, from March 2010 to March 2016. He has extensive experience in international management consulting, having retired from Accenture (UK) Limited, a leading global professional services firm, in March 2010, after holding the position of Senior Adviser from January 2008 to March 2010 and International Chairman from January 2001 to December 2007 and holding other major operational roles prior to 2001. Select Non-Public Directorships and Committees: Britten Pears Arts [Chairman] Live Music Now [Chairman] Martin Randall Travel Ltd. [Chairman] | |
| 2022 Nominees for Director | | | Principal Occupation and Business Experience | |
| ![]() Independent Director Director Since: 2014 Age: 65 | | | Nicholas Fanandakis has served as Senior Adviser to the Chief Executive Officer of DuPont de Nemours, Inc. (“DuPont”), a leading global research and technology-based science company, since February 2020. In June 2019, Mr. Fanandakis retired as an Executive Vice President of DuPont after 40 years of service. Mr. Fanandakis helped lead the company through the merger with The Dow Chemical Company, and then subsequent separations. From November 2009 to September 1, 2017, Mr. Fanandakis served as Chief Financial Officer and Executive Vice President of DuPont and led the company through major portfolio transformations. Mr. Fanandakis joined DuPont in 1979 as an accounting and business analyst. Since then, Mr. Fanandakis served in a variety of plant, marketing, product management and business director roles. Mr. Fanandakis served as Group Vice President of DuPont Applied BioSciences from 2008 to 2009. Mr. Fanandakis also served as Vice President and General Manager of DuPont Chemical Solutions Enterprise from 2003 until February 2007, when he was named Vice President of DuPont Corporate Plans. Public Company Directorships and Committees: Duke Energy Corp. [Member of Audit Committee and Finance and Risk Management Committee] ITT Inc. [Member of Audit Committee and Compensation and Personnel Committee] | |
| ![]() Director Since: 2014 Age: 64 | | | Steven Gunby joined the Company as its President and Chief Executive Officer on January 20, 2014. Mr. Gunby has extensive experience in the consulting services industry, having formerly been employed by The Boston Consulting Group, a leading business strategy consulting services firm, for more than 30 years, beginning in August 1983. The positions he held with The Boston Consulting Group include Global Leader, Transformation, from January 2011 to January 2014, and Chairman, North and South America, from December 2003 to December 2009. He also held other major managerial roles in his capacity as a Senior Partner and Managing Director since 1993, including serving as a member of The Boston Consulting Group’s Executive Committee. Public Company Directorships and Committees: Arrow Electronics, Inc. [Member of Audit Committee and Chair of Compensation Committee] | |
| 2022 Nominees for Director | | | Principal Occupation and Business Experience | |
| ![]() Independent Director Chairman of the Board Since: 2013 Director Since: 2004 Age: 72 | | | Gerard Holthaus has served as the Lead independent Director of WillScot Mobile Mini Holdings Corp., a leading provider of modular space solutions in North America, since July 2020. Mr. Holthaus served as independent non-executive Chairman of the Board of Directors of WillScot Corp. from November 2017 up to and until the merger of Mobile Mini Corp. into WillScot Corp. in July 2020. Prior to November 2017, Mr. Holthaus served as non-executive Chairman of the Board of Directors of Algeco Scotsman Global S.a.r.l. and its holding company, Algeco/Scotsman Holdings S.a.r.l., a leading global provider of modular space solutions, positions that he held since April 2010. From October 2007 to April 2010, Mr. Holthaus held the positions of Executive Chairman of the Board of Directors and Chief Executive Officer of Algeco Scotsman Global S.a.r.l. Public Company Directorships and Committees: WillScot Mobile Mini Holdings Corp. [Lead Independent Director] [Member of Audit Committee and Related-Party Transactions Committee and Chair of Nominating and Corporate Governance Committee] Past Public Company Directorships: Algeco Scotsman Global S.a.r.l. BakerCorp International, Inc. Neff Corporation Nesco Holdings, Inc. Select Non-Public Directorships and Committees: Saint Joseph Hospital [Trustee] The Baltimore Life Companies [Chairman of the Board] [Member of Nominating and Corporate Governance Committee] | |
| ![]() Independent Director Director Since: 2022 Age: 52 | | | Nicole Jones has been Executive Vice President and General Counsel of Cigna Corporation (“Cigna”), a multinational managed healthcare and insurance company, since 2011. During 2010, Ms. Jones served as Senior Vice President and General Counsel for Lincoln Financial Group (“Lincoln Financial”), a holding company operating insurance and investment management businesses. Prior to joining Lincoln Financial, from 2006 to 2010, Ms. Jones held various other positions with Cigna, including Deputy General Counsel, Corporate Secretary and Chief Counsel of Domestic Health Service, Securities and Investment Law. Ms. Jones has also held roles in corporate law departments at Johnson & Johnson, a multinational corporation that develops medical devices, pharmaceuticals and consumer packaged goods, MCI, Inc., a telecommunications company acquired by Verizon in 2006, and International Paper Company, a pulp and paper corporation. | |
| 2022 Nominees for Director | | | Principal Occupation and Business Experience | |
| ![]() Independent Director Director Since: 2022 Age: 65 | | | Stephen C. Robinson is a retired partner of the law firm of Skadden, Arps, Slate, Meagher & Flom LLP (“Skadden”), a multinational law firm. Mr. Robinson joined Skadden in 2010 practicing in its litigation department, with a focus on government enforcement and white-collar crime, until his retirement in 2021. Mr. Robinson previously served as a U.S. District Judge for the U.S. District Court for the Southern District of New York from 2003 to 2010, for which he was nominated by President George W. Bush. Prior to serving on the Southern District court, Mr. Robinson held several other positions in government. From 1998 to 2001, he served as a U.S. Attorney for the District of Connecticut, for which he was nominated by President William J. Clinton. From 1998 to 2001, he served as Principal Deputy General Counsel for the Federal Bureau of Investigation. Mr. Robinson has also served in multiple leadership and management roles, including as the Chief Executive Officer of Empower New Haven, a nonprofit agency focused on urban development social services, from 2002 to 2003, and as the Chief Compliance Officer of Aetna U.S. Healthcare, a managed health care company, from 1996 to 1998. Public Company Directorships and Committees: Dycom Industries, Inc. Select Non-Public Directorships and Committees: Cornell University [Trustee] Lincoln Center for the Performing Arts [Trustee] Weill Cornell Medicine [Trustee] The New York Community Trust [Trustee] Weill Cornell Medicine [Trustee] | |
| ![]() Independent Director Director Since: 2016 Age: 60 | | | Laureen Seeger is Chief Legal Officer of the American Express Company, a diversified financial services company, having previously held the title of Executive Vice President and General Counsel from July 2014 to July 2018. From March 2006 through June 2014, Ms. Seeger served as Executive Vice President, General Counsel and Chief Compliance Officer at McKesson Corporation, the largest healthcare services company in North America, where she led the Law, Public Affairs, Compliance and Corporate Secretary functions, while guiding the company through complex legal and regulatory environments and contributing to its financial growth. Ms. Seeger joined McKesson in 2000 as General Counsel of its Technology Division. In this role, she provided leadership through complex merger and acquisition transactions and product evolutions while building the Law Department and enhancing client service. Select Non-Public Directorships and Committees: Central Park Conservancy [Trustee] University of Wisconsin Foundation and Alumni Association [Member of Development Committee and Governance Committee] | |
| | | Board of Directors | | | Audit Committee | | | Compensation Committee | | | Nominating, Corporate Governance and Social Responsibility Committee | |
| Total Meetings Held | | | 8 | | | 6 | | | 7 | | | 5 | |
| Name | | | Audit | | | Compensation | | | Nominating, Corporate Governance and Social Responsibility | |
| Brenda J. Bacon | | | | | • | | | Chair | | |
| Mark S. Bartlett | | | • | | | | | | ||
| Claudio Costamagna | | | | | Chair | | | | ||
| Vernon Ellis | | | • | | | | | • | | |
| Nicholas C. Fanandakis | | | Chair | | | | | | ||
| Gerard E. Holthaus | | | • | | | • | | | | |
| Laureen E. Seeger | | | | | • | | | • | |
| COMMITTEE | | | WEBSITE LINK | |
| Audit Committee | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/charter-of-the- audit-committee-of-the-board-of-directors.pdf | |
| Compensation Committee | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/charter-of-the- compensation-committee-of-the-board-of-directors.pdf | |
| Nominating, Corporate Governance and Social Responsibility Committee | | | https://www.fticonsulting.com/-/media/files/us-files/our-firm/guidelines/charter-of-the- nominating-corporate-governance-and-social-responsibility-committee-of-the-board.pdf | |
| ◾ | | | selects, oversees and retains our independent registered public accounting firm; | |
| ◾ | | | reviews and discusses the scope of the annual audit and written communications by our independent registered public accounting firm to the Audit Committee and management; | |
| ◾ | | | oversees our financial reporting activities, including the annual audit and the accounting standards and principles we follow; | |
| ◾ | | | approves audit and non-audit services by our independent registered public accounting firm and applicable fees; | |
| ◾ | | | reviews and discusses our periodic reports filed with the SEC; | |
| ◾ | | | reviews and discusses our earnings press releases and communications with financial analysts and investors; | |
| ◾ | | | oversees our internal audit activities; | |
| ◾ | | | oversees our disclosure controls and procedures; | |
| ◾ | | | reviews Section 404 of the Sarbanes-Oxley Act of 2002, internal control over financial reporting; | |
| ◾ | | | oversees and monitors our Policy on Reporting Concerns and Non-Retaliation and related reports; | |
| ◾ | | | reviews and discusses risk assessment and risk management policies and practices; | |
| ◾ | | | oversees the administration of the Code of Ethics and Business Conduct and other ethics policies; | |
| ◾ | | | reviews, discusses and approves insider and affiliated person transactions; | |
| ◾ | | | administers the policy with respect to the hiring of former employees of the Company’s independent registered public accounting firm; | |
| ◾ | | | performs an annual self-evaluation of the Audit Committee; | |
| ◾ | | | reviews the Audit Committee Charter and recommends changes to the Nominating, Corporate Governance and Social Responsibility Committee for submission to the Board for approval; and | |
| ◾ | | | prepares the Audit Committee Report required to be included in the annual proxy statement. | |
| ◾ | | | approves the compensation of our CEO; | |
| ◾ | | | administers our equity-based compensation plans and approves awards under such plans; | |
| ◾ | | | establishes objective performance goals, individual award levels, and operative and subjective performance measures and oversees all aspects of executive officer incentive compensation; | |
| ◾ | | | reviews and approves, or recommends that the Board approve, employment, consulting and other contracts or arrangements with present and former executive officers; | |
| ◾ | | | reviews the compensation disclosures in the annual proxy statement and Annual Report on Form 10-K filed with the SEC and discusses the disclosures with management; | |
| ◾ | | | performs annual performance evaluations of our CEO and reviews the CEO’s annual performance evaluations of other executive officers, in conjunction with the independent Chairman of the Board or other presiding director, as applicable, and Chair of the Nominating, Corporate Governance and Social Responsibility Committee; | |
| ◾ | | | performs an annual self-evaluation of the Compensation Committee; | |
| ◾ | | | reviews the Compensation Committee Charter and recommends changes to the Nominating, Corporate Governance and Social Responsibility Committee for submission to the Board for approval; | |
| ◾ | | | prepares the Compensation Committee Report included in the annual proxy statement; | |
| ◾ | | | submits all equity-based compensation plans, executive officer compensation plans and material revisions to such plans to a vote of the Board and to a vote of shareholders if shareholder approval is required; and | |
| ◾ | | | ensures that shareholders have the opportunity to vote on (i) an advisory (non-binding) resolution to approve the compensation of the Company’s NEOs in accordance with the frequency selected by shareholders and (ii) the frequency of the shareholder advisory (non-binding) vote to approve the resolution approving the compensation of the NEOs at least once every six years. | |
| ◾ | | | identifies and qualifies the annual slate of directors for nomination by the Board; | |
| ◾ | | | reviews non-employee director compensation and recommends changes to the Board for approval; | |
| ◾ | | | assesses the independence of directors for the Board; | |
| ◾ | | | identifies and qualifies the candidates for Chairman of the Board and for membership and chairmanship of the Committees for appointment by the Board; | |
| ◾ | | | identifies and qualifies candidates to fill vacancies occurring between annual meetings of shareholders for election by the Board; | |
| ◾ | | | monitors compliance with, and reviews proposed changes to, our Corporate Governance Guidelines, the Committee Charters, and other policies and practices relating to corporate governance for submission to the Board for approval; | |
| ◾ | | | monitors and reviews responses to shareholder communications with non-management directors together with the independent Chairman of the Board or presiding director, as applicable; | |
| ◾ | | | oversees the process for director education; | |
| ◾ | | | oversees the process for Board and Committee annual self-evaluations; | |
| ◾ | | | oversees the process for performance evaluations of our executive officers in conjunction with our independent Chairman of the Board and the Compensation Committee; | |
| ◾ | | | oversees the process relating to succession planning for our CEO and other executive officer positions; | |
| ◾ | | | reviews directors’ and officers’ liability insurance terms and limits; | |
| ◾ | | | oversees, and reports to the Board and other interested Committees, regarding social responsibility, human capital and ESG-related factors; | |
| ◾ | | | reviews and discusses with management the Company’s reports that address ESG-related topics; | |
| ◾ | | | reviews the Nominating, Corporate Governance and Social Responsibility Committee Charter and recommends changes to the Board for approval; | |
| ◾ | | | reviews the annual proxy statement disclosures, including those pertaining to the nomination of directors, the election of directors, the independence of directors, corporate governance and ESG; and | |
| ◾ | | | performs an annual self-evaluation of the Nominating, Corporate Governance and Social Responsibility Committee. | |
| | | | |||||||||
| | Compensation Elements | | | 2021 Director Compensation Values (1) (5) ($) | | | Alternative Forms of Payment | | | ||
| | Annual Retainer: (2) (5) (6) | | | 50,000 | | | Cash or Deferred Stock Units | | | ||
| | Annual Committee Chair Fees: (2) (5) | | | 10,000 — Chair of Audit Committee 7,500 — Chair of Compensation Committee 5,000 — Chair of Nominating, Corporate Governance and Social Responsibility Committee | | | Cash or Deferred Stock Units | | | ||
| | Additional Annual Non-Employee Chairman of the Board Fee: (2) (5) | | | 200,000 | | | Cash or Deferred Stock Units | | | ||
| | Annual Equity Award: (2) (3) (4) (5) (6) | | | 250,000 | | | Restricted Stock, Restricted Stock Units, Deferred Restricted Stock Units or Cash | | |
(1) | Continuing non-employee directors receive payment of the annual retainer and annual equity award, and Chairman of the Board or Committee Chair fee, if applicable, as of the date of each annual meeting of shareholders. A new non-employee director receives a prorated annual retainer and equity award upon first being elected to the Board other than at an annual meeting. A non-employee director, who is appointed to a chairmanship other than following an annual meeting, receives a prorated non-executive Chairman of the Board or Committee Chair fee, as applicable. |
(2) | U.S. non-employee directors are permitted to voluntarily defer annual retainer payments (including any annual fee to the non-executive Chairman of the Board or a Committee Chair) and/or annual equity compensation awards in the form of deferred stock units or deferred restricted stock units, respectively. Deferred stock units awarded on account of deferred annual retainer and Chairman of the Board and/or Committee Chair fees are vested in full on the grant date. Deferred restricted stock units granted on account of deferred annual equity compensation awards vest in full on the first anniversary of the grant date unless vesting is accelerated as described in footnote (4) below. Each deferred stock unit and deferred restricted stock unit represents the right to receive one share of Common Stock upon the earliest of (i) a separation from service event, (ii) an elected payment date, and (iii) certain other permissible payment events, in each case, in accordance with Code Section 409A of the Internal Revenue Code. |
(3) | The annual equity award, unless deferred, is in the form of shares of restricted stock, in the case of U.S. non-employee directors, and restricted stock units, in the case of non-U.S. non-employee directors. Each restricted stock unit represents the right to receive one share of Common Stock upon vesting. Annual equity awards are non-transferable and vest in full on the first anniversary of the grant date unless vesting is accelerated as described in footnote (4) below. |
(4) | All unvested shares of restricted stock and restricted stock units will immediately vest in full upon a non-employee director’s (i) death, (ii) “Disability” (as defined in the Director Plan), (iii) cessation of service within one year following a Change in Control unless other accommodations are made with respect to such awards, (iv) cessation of service at the expiration of his or her term as a director due to the Company’s failure to renominate such director for service on the Board (other than for “Cause” (as determined by the Board, in its good-faith discretion), due to the request of such director or as a result of a voluntary resignation), or (v) cessation of service due to failure of the Company’s shareholders to elect such director for service on the Board (other than for “Cause” (as determined by the Board, in its good-faith discretion)). |
(5) | The number of (i) deferred stock units awarded to a non-employee director as annual retainer compensation (including any annual fee to the non-executive Chairman of the Board or a Committee Chair) and (ii) shares of restricted stock, restricted stock units and deferred restricted stock units awarded to a non-employee director as annual equity compensation will be determined by dividing (a) the U.S. dollar value of such award by (b) the closing price per share of Common Stock reported on the NYSE for the grant date. Fractional restricted shares, restricted stock units, deferred stock units and deferred restricted share units are rounded down to the nearest whole share. |
(6) | If we do not have sufficient shares of Common Stock authorized under our shareholder-approved equity compensation plan to fund annual retainer and equity awards in stock-based awards, such awards will be funded in cash. The payout of such cash amounts will be subject to the terms of the applicable deferred compensation payment and vesting and accelerated vesting conditions, including the requirements of Code Section 409A. Such cash amounts generally will accrue interest at the rate of 6% per annum. |
| Name | | | Fees Earned or Paid in Cash ($) (a) | | | Stock Awards (1) ($) (b) | | | Option Awards (1) ($) (c) | | | All Other Compensation (2) ($) (d) | | | Total ($) (e) | |
| 2021 Non-Employee Directors: | | | | | | | | | | | | |||||
| Brenda J. Bacon | | | 55,000 | | | 249,960 | | | — | | | — | | | 304,960 | |
| Mark S. Bartlett | | | 50,000 | | | 249,960 | | | — | | | — | | | 299,960 | |
| Claudio Costamagna | | | 57,500 | | | 249,960 | | | — | | | — | | | 307,460 | |
| Vernon Ellis | | | 50,000 | | | 249,960 | | | — | | | — | | | 299,960 | |
| Nicholas C. Fanandakis | | | 60,000 | | | 249,960 | | | — | | | — | | | 309,960 | |
| Gerard E. Holthaus | | | 250,000 | | | 249,960 | | | — | | | — | | | 499,960 | |
| Laureen E. Seeger | | | — | | | 299,871 | | | — | | | — | | | 299,871 | |
(1) | The balances of each non-employee director’s equity-based awards as of December 31, 2021 (excluding vested shares of Common Stock) are set forth in the table below: |
| | | | |||||||||||||||
| | Name | | | Unvested Restricted Shares or Restricted Stock Units | | | Vested Deferred Stock or Deferred Restricted Stock Units | | | Unvested Deferred Stock or Deferred Restricted Stock Units | | | Unexercised Stock Options | | |||
| | 2021 Non-Employee Directors: | | | | | | | | | | |||||||
| | Brenda J. Bacon | | | 1,848 | | | — | | | — | | | — | | |||
| | Mark S. Bartlett | | | 1,848 | | | — | | | — | | | — | | |||
| | Claudio Costamagna | | | 1,848 | | | — | | | — | | | — | | |||
| | Vernon Ellis | | | 1,848 | | | — | | | — | | | — | | |||
| | Nicholas C. Fanandakis | | | 1,848 | | | 1,994 | | | — | | | — | | |||
| | Gerard E. Holthaus | | | 1,848 | | | 37,500 | | | — | | | — | | |||
| | Laureen E. Seeger | | | — | | | 369 | | | 1,848 | | | — | |
(2) | No current director received perquisites or other benefits aggregating more than $10,000 in 2021. |
| Name of Policy | | | Website Link | |
| Standards of Director Independence | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/categorical-standards- for-director-independence.pdf | |
| Corporate Governance Guidelines | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-corporate- governance-guidelines.pdf | |
| Code of Ethics and Business Conduct | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-code-of-conduct.pdf | |
| Anti-Corruption Policy | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/anti-corruption-policy.pdf | |
| Policy on Reporting Concerns and Non-Retaliation | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-on-reporting- concerns-and-non-retaliation.pdf | |
| Policy on Disclosure Controls | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-on-disclosure- controls.pdf | |
| Policy on Inside Information and Insider Trading | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-statement-on- inside-information-and-insider-trading.pdf | |
| ◾ | | | Annual Director Elections. Shareholders elect our directors annually to hold office until the next annual meeting of shareholders and until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or removal (whichever occurs earliest). | |
| ◾ | | | Non-Employee Independent Chairman of the Board. Gerard E. Holthaus is our non-employee independent Chairman of the Board. More information about our Chairman of the Board may be found in the section titled “— Board Leadership Structure” on page 26 of this Proxy Statement. | |
| ◾ | | | Majority Voting in Uncontested Director Elections. A nominee in an uncontested election shall be elected as a director only if such nominee receives the affirmative vote of a majority of the total votes cast “FOR” and “WITHHELD” as to such nominee at a meeting. Any abstentions or broker non-votes are not counted as votes cast either “FOR” or “WITHHELD” with respect to a director’s election and will have no effect on the election of directors. | |
| ◾ | | | Director Resignation. Our Corporate Governance Guidelines provide that in an uncontested election, if an incumbent director fails to receive the required majority vote, he or she must offer to resign from the Board. The Nominating, Corporate Governance and Social Responsibility Committee will (a) consider such offer to resign, (b) determine whether to accept such director’s resignation, and (c) submit such recommendation for consideration by the Board. The director whose offer to resign is under consideration may not participate in any deliberation or vote of the Nominating, Corporate Governance and Social Responsibility Committee or the Board regarding his or her offer of resignation. In the event that all directors offer to resign in accordance with our resignation policy, the Nominating, Corporate Governance and Social Responsibility Committee will make | |
| | | a final determination as to whether to recommend to the Board to accept all offers to resign, including those offers made by members of the Nominating, Corporate Governance and Social Responsibility Committee. The Nominating, Corporate Governance and Social Responsibility Committee and the Board may consider any factors they deem relevant in deciding whether to accept a director’s offer to resign. Within 90 days after the date of certification of the election results, the Board will publicly disclose the Board’s decision of whether or not to accept an offer of resignation. If such incumbent director’s offer to resign is not accepted by the Board, such director will continue to serve until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or removal (whichever occurs earliest). If a director’s offer to resign is accepted by the Board, then the Board, in its sole discretion, may fill any resulting vacancy pursuant to the Company’s Bylaws or reduce the size of the Board. | | |
| ◾ | | | Executive Sessions. Our Board meets regularly in executive sessions, without the presence of management, including our CEO. | |
| ◾ | | | Shareholder Rights Plan. We do not have a shareholder rights plan and are not currently considering adopting one. | |
| ◾ | | | Shareholder Power to Amend Bylaws. Our shareholders, by the affirmative vote of the holders of a majority of the shares of Common Stock entitled to vote, have the power to adopt, alter or repeal any Bylaw of the Company. | |
| Name of Policy | | | Website Link | |
| Environmental Responsibility & Climate Change Disclosure Policy | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting- environmental-climate-change-disclosure-policy.pdf | |
| Global Health & Safety Policy | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-global- health-safety-policy.pdf | |
| Human Rights Policy | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-human- rights-policy.pdf | |
| 2020 Corporate Sustainability Report | | | https://www.fticonsulting.com/insights/reports/corporate-sustainability-report-2020 | |
| Vendor Code of Conduct | | | https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/vendor-code-of- conduct.pdf | |
| ◾ | | | PROVIDE our NEOs with competitive total pay opportunities to retain, motivate and attract talented executive officers. | |
| ◾ | | | MAINTAIN continuity of executive management by delivering opportunities for our CEO and other NEOs to earn competitive compensation. | |
| ◾ | | | Structure our executive compensation program to ALIGN THE INTERESTS of our CEO and other NEOs with those of our shareholders by encouraging solid corporate growth and the prudent management of risks and rewards. | |
| ◾ | | | BALANCE the emphasis on short-term and long-term compensation opportunities, focusing on the attainment of financial and strategic goals that contribute to the creation of shareholder value. | |
| ◾ | | | Place a significant percentage of each NEO’s total compensation opportunity AT-RISK and subject to the attainment of financial goals that drive or measure the creation of shareholder value. | |
| ◾ | | | Pay-for-PERFORMANCE. | |
| ◾ | | | Manage our executive compensation program CONSISTENTLY among our CEO and other participating NEOs. | |
| ◾ | | | Limit perquisites and other non-performance-based entitlements. | |
| ◾ | | | each of the NEOs named in this Proxy Statement; | |
| ◾ | | | each person known by us to own beneficially more than 5% of our outstanding shares of Common Stock; | |
| ◾ | | | each of our directors and director nominees; and | |
| ◾ | | | all of our executive officers and directors as a group. | |
| Name of Beneficial Owner (1) | | | Number of Common Shares Owned | | | Unvested Restricted Shares | | | Right to Acquire Vested and Exercisable Stock-Based Options (2) | | | Total Shares Beneficially Owned | | | Percentage of Shares Beneficially Owned (%) | |
| Steven H. Gunby | | | 464,578 | | | 30,872 | | | 227,904 | | | 723,354 | | | 2.10 | |
| Ajay Sabherwal | | | 13,447 | | | 4,289 | | | 13,065 | | | 30,801 | | | * | |
| Paul Linton | | | 37,970 | | | 4,290 | | | 92,805 | | | 135,065 | | | * | |
| Curtis P. Lu | | | 27,960 | | | 4,290 | | | 13,663 | | | 45,913 | | | * | |
| Holly Paul | | | 22,485 | | | 4,290 | | | 2,477 | | | 29,252 | | | * | |
| Brenda J. Bacon | | | 13,494 | | | 1,848 | | | — | | | 15,342 | | | * | |
| Mark S. Bartlett | | | 30,553 | | | 1,848 | | | — | | | 32,401 | | | * | |
| Claudio Costamagna | | | 43,879 | | | — | | | — | | | 43,879 | | | * | |
| Vernon Ellis | | | 27,087 | | | — | | | — | | | 27,087 | | | * | |
| Nicholas C. Fanandakis (3) | | | 6,800 | | | 1,848 | | | — | | | 8,648 | | | * | |
| Gerard E. Holthaus (4) | | | 66,637 | | | 1,848 | | | — | | | 68,485 | | | * | |
| Nicole S. Jones (5) | | | — | | | 317 | | | — | | | 317 | | | * | |
| Stephen C. Robinson (5) | | | — | | | 317 | | | — | | | 317 | | | * | |
| Laureen E. Seeger (6) | | | 23,751 | | | — | | | — | | | 23,751 | | | * | |
| BlackRock, Inc. (7) 55 East 52nd Street New York, NY 10055 | | | 2,839,899 | | | — | | | — | | | 2,839,899 | | | 8.30 | |
| Kayne Anderson Rudnick Investment Management LLC (8) 1800 Avenue of the Stars, 2nd Floor Los Angeles, CA 90067 | | | 3,680,913 | | | — | | | — | | | 3,680,913 | | | 10.74 | |
| Mawer Investment Management Ltd. (9) 600, 517 – 10th Avenue SW Calgary, Alberta, Canada T2R 0A8 | | | 4,317,747 | | | — | | | — | | | 4,317,747 | | | 12.59 | |
| The Vanguard Group (10) 100 Vanguard Blvd. Malvern, PA 19355 | | | 3,142,708 | | | — | | | — | | | 3,142,708 | | | 9.17 | |
| All directors and executive officers as a group (15 persons) | | | 780,640 | | | 60,558 | | | 349,914 | | | 1,191,112 | | | 3.46 | |
(1) | Unless otherwise specified, the address of these persons is c/o FTI Consulting, Inc.’s executive office at 555 12th Street NW, Suite 700, Washington, D.C. 20004. |
(2) | No stock options, stock-based units or other rights to acquire shares of Common Stock will vest or become exercisable within 60 days of the Record Date. |
(3) | The reported beneficial ownership of Nicholas C. Fanandakis excludes 1,994 shares of Common Stock issuable on account of vested deferred stock units. |
(4) | The reported beneficial ownership of Gerard E. Holthaus excludes 37,500 shares of Common Stock issuable on account of vested deferred stock units. |
(5) | The beneficial ownership of each of Nicole S. Jones and Stephen C. Robinson is reported as of March 22, 2022, the date of his and her election as a director of the Company. |
(6) | The reported beneficial ownership of Laureen E. Seeger excludes 369 shares of Common Stock issuable on account of vested deferred stock units and 1,848 shares of Common Stock issuable on account of unvested deferred stock units. |
(7) | Information is based on Schedule 13G/A filed with the SEC on February 1, 2022 reporting (i) sole power to vote or direct the vote of 2,709,459 shares, (ii) shared power to vote or direct the vote of zero shares, (iii) sole power to dispose or direct the disposition of 2,839,899 shares, and (iv) shared power to dispose or direct the disposition of zero shares of the Company’s Common Stock. BlackRock, Inc. reports that various persons have the right to receive or the power to direct the receipt of dividends, or the proceeds from the sale of our Common Stock, and no one person’s interest in the Common Stock is more than 5% of our total outstanding shares of Common Stock. |
(8) | Information is based on Schedule 13G/A filed with the SEC on February 14, 2022 reporting (i) sole power to vote or direct the vote of 2,544,363 shares, (ii) shared power to vote or direct the vote of 876,330 shares, (iii) sole power to dispose or direct the disposition of 2,804,583 shares, and (iv) shared power to dispose or direct the disposition of 876,330 shares of the Company’s Common Stock. |
(9) | Information is based on Schedule 13G/A filed with the SEC on February 10, 2022 reporting (i) sole power to vote or direct the vote of 4,137,947 shares, (ii) shared power to vote or direct the vote of zero shares, (iii) sole power to dispose or direct the disposition of 4,317,747 shares, and (iv) shared power to dispose or direct the disposition of zero shares of the Company’s Common Stock. |
(10) | Information is based on Schedule 13G/A filed with the SEC on February 10, 2022 reporting (i) sole power to vote or direct the vote of zero shares, (ii) shared power to vote or direct the vote of 18,765 shares, (iii) sole power to dispose or direct the disposition of 3,094,924 shares, and (iv) shared power to dispose or direct the disposition of 47,784 shares of the Company’s Common Stock. The Vanguard Group reports that its clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends, or the proceeds from the sale of our Common Stock, and no one other person’s interest in the Common Stock is more than 5% of our total outstanding shares of Common Stock. |